Strikingly, tumor growth was completely eradicated in this model, with all mice receiving the full combination treatment (STING agonist + anti-PD1/anti-VEGFR2 + anti-CD19/anti-B220) achieving complete responses (Fig. 4B, C). This evidence concerns the gene PTPRC and neoplasm.